IDO1 and triple-negative breast carcinoma: In triple-negative breast cancer, Indoleamine 2,3 – Dioxygenase 1 (IDO-1) upregulation increases HLA-G expression, thereby suppressing NK cell antitumor activity; blockade of IDO-1 can restore NK cell cytotoxicity (28).